Search research articles
Contact Us
Filters
Showing results (591-600 of 953) with videos related to
Page
of 96
Sort By:
Food & Function
|
April 17, 2023
<i>Lactobacillus coryniformis</i> subsp<i>. torquens</i> inhibits bone loss in obese mice <i>via</i> modification of the gut microbiota
W Song, Y Y Bai, J H Hu, et al.
British Journal of Cancer
|
June 21, 2017
MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
P Zhang, W M Tang, H Zhang, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
October 8, 2025
ABHD6 suppression attenuates pro-inflammatory responses in mice and promotes anti-inflammatory polarization of macrophages during endotoxin stress
P Poursharifi, C Schmitt, I Chenier, et al.
World Neurosurgery
|
March 21, 2021
Anatomy and White Matter Connections of the Middle Frontal Gyrus
Robert G Briggs, Yueh-Hsin Lin, Nicholas B Dadario, et al.
Zhonghua Fu Chan Ke Za Zhi
|
August 25, 2025
[Real world clinical data analysis of fuzuloparib for the treatment of ovarian epithelial cancer patients]
D H Weng, J Jiang, Y J Yang, et al.
International Journal of Oral and Maxillofacial Surgery
|
July 30, 2019
Chinese expert group consensus on diagnosis and clinical management of osteoradionecrosis of the mandible
Y He, C Ma, J Hou, et al.
Scientific Reports
|
January 5, 2017
Superconductivity Bordering Rashba Type Topological Transition
M L Jin, F Sun, L Y Xing, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 6, 2020
[Progress on clinical trials of cancer drugs in China, 2019]
H Y Huang, D W Wu, H X Wang, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Page
of 96
Search research articles
Search
Showing results (591-600 of 953) with videos related to
Sort By:
Page
of 96
Food & Function
|
April 17, 2023
<i>Lactobacillus coryniformis</i> subsp<i>. torquens</i> inhibits bone loss in obese mice <i>via</i> modification of the gut microbiota
W Song, Y Y Bai, J H Hu, et al.
British Journal of Cancer
|
June 21, 2017
MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
P Zhang, W M Tang, H Zhang, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
October 8, 2025
ABHD6 suppression attenuates pro-inflammatory responses in mice and promotes anti-inflammatory polarization of macrophages during endotoxin stress
P Poursharifi, C Schmitt, I Chenier, et al.
World Neurosurgery
|
March 21, 2021
Anatomy and White Matter Connections of the Middle Frontal Gyrus
Robert G Briggs, Yueh-Hsin Lin, Nicholas B Dadario, et al.
Zhonghua Fu Chan Ke Za Zhi
|
August 25, 2025
[Real world clinical data analysis of fuzuloparib for the treatment of ovarian epithelial cancer patients]
D H Weng, J Jiang, Y J Yang, et al.
International Journal of Oral and Maxillofacial Surgery
|
July 30, 2019
Chinese expert group consensus on diagnosis and clinical management of osteoradionecrosis of the mandible
Y He, C Ma, J Hou, et al.
Scientific Reports
|
January 5, 2017
Superconductivity Bordering Rashba Type Topological Transition
M L Jin, F Sun, L Y Xing, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
March 6, 2020
[Progress on clinical trials of cancer drugs in China, 2019]
H Y Huang, D W Wu, H X Wang, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Page
of 96